{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:29:01Z","timestamp":1780507741740,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ygyno.2021.01.006","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:12:45Z","timestamp":1610928765000},"page":"194-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Impact of intra-operative factors upon peri-operative outcomes in women undergoing hyperthermic intraperitoneal chemotherapy for gynecologic cancer"],"prefix":"10.1016","volume":"161","author":[{"given":"Anna","family":"Chichura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony B.","family":"Costales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Gruner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad M.","family":"Michener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Debernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ygyno.2021.01.006_bb0005","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ygyno.2021.01.006_bb0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ygyno.2007.03.019","article-title":"Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery","volume":"106","author":"Bae","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2021.01.006_bb0015","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1245\/s10434-014-3599-4","article-title":"Treatment of microscopic disease with hyperthermic intraoperative intraperitoneal chemotherapy after complete cytoreduction improves disease-free survival in patients with stage IIIC\/IV ovarian cancer","volume":"21","author":"Cascales-Campos","year":"2014","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.01.006_bb0020","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ygyno.2021.01.006_bb0025","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ejso.2013.09.030","article-title":"Peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients","volume":"39","author":"Bakrin","year":"2013","journal-title":"Eur. J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2021.01.006_bb0030","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ejso.2016.09.008","article-title":"Best practice for perioperative management of patients with cytoreductive surgery and HIPEC","volume":"43","author":"Rasp\u00e9","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2021.01.006_bb0035","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2044.2007.05380.x","article-title":"Peri-operative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"63","author":"Schmidt","year":"2008","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ygyno.2021.01.006_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7819-9-169","article-title":"Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC)","volume":"9","author":"Cooksley","year":"2011","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2021.01.006_bb0045","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/307317","article-title":"Intensive care unit admission after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Is it necessary?","volume":"2014","author":"L\u00f3pez-Basave","year":"2014","journal-title":"J. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.01.006_bb0050","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1245\/s10434-007-9701-4","article-title":"Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center","volume":"15","author":"Gusani","year":"2008","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.01.006_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7819-12-136","article-title":"Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience","volume":"12","author":"Kajdi","year":"2014","journal-title":"World J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.01.006_bb0060","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ygyno.2020.06.487","article-title":"A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology","volume":"158","author":"Chambers","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.01.006_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J. Biomed. Inform."},{"issue":"2","key":"10.1016\/j.ygyno.2021.01.006_bb0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"issue":"4","key":"10.1016\/j.ygyno.2021.01.006_bb0075","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3390\/jcm9040953","article-title":"Elevated lactate levels in acute pulmonary embolism are associated with prothrombotic fibrin clot properties: contribution of NETs formation","volume":"9","author":"Z\u0105bczyk","year":"2020","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2021.01.006_bb0080","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jamasurg.2013.3640","article-title":"Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the American College of Surgeons National Surgical Quality Improvement Program","volume":"149","author":"Jafari","year":"2014","journal-title":"JAMA Surg."},{"issue":"1","key":"10.1016\/j.ygyno.2021.01.006_bb0085","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1378\/chest.15-1703","article-title":"Lactic acidosis in sepsis: it\u2019s not all anaerobic: implications for diagnosis and management","volume":"149","author":"Suetrong","year":"2016","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ygyno.2021.01.006_bb0090","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/SHK.0b013e318167378f","article-title":"Increased aerobic glycolysis through \u03b22 stimulation is a common mechanism involved in lactate formation during shock states","volume":"30","author":"Levy","year":"2008","journal-title":"Shock"},{"issue":"4","key":"10.1016\/j.ygyno.2021.01.006_bb0095","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s11605-015-2743-1","article-title":"A randomized trial of goal directed vs standard fluid therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"19","author":"Colantonio","year":"2015","journal-title":"J. Gastrointest. Surg."},{"issue":"1","key":"10.1016\/j.ygyno.2021.01.006_bb0100","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00003246-199201000-00020","article-title":"Lactic acidosis in critical illness","volume":"20","author":"Mizock","year":"1992","journal-title":"Crit. Care Med."},{"issue":"10","key":"10.1016\/j.ygyno.2021.01.006_bb0105","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/emj.2007.055558","article-title":"Lactic acidosis not hyperlactatemia as a predictor of inhospital mortality in septic emergency patients","volume":"25","author":"Lee","year":"2008","journal-title":"Emerg. Med. J."},{"issue":"24","key":"10.1016\/j.ygyno.2021.01.006_bb0110","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1056\/NEJMra1309483","article-title":"Lactic acidosis","volume":"371","author":"Kraut","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ygyno.2021.01.006_bb0115","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ki.1986.62","article-title":"Lactic acidosis","volume":"29","author":"Madias","year":"1986","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.ygyno.2021.01.006_bb0120","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1245\/s10434-019-07644-w","article-title":"Standard operating procedures for anesthesia management in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improve patient outcomes: a patient cohort analysis","volume":"26","author":"Fichmann","year":"2019","journal-title":"Ann. Surg. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2021.01.006_bb0125","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4103\/ija.IJA_765_19","article-title":"Society of onco-anaesthesia and perioperative care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)","volume":"63","author":"Solanki","year":"2019","journal-title":"Indian J. Anaesth."},{"issue":"5","key":"10.1016\/j.ygyno.2021.01.006_bb0130","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/SHK.0000000000001415","article-title":"Lactic acidosis and the role of sodium bicarbonate: a narrative opinion","volume":"53","author":"Rudnick","year":"2020","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.ygyno.2021.01.006_bb0135","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1378\/chest.117.1.260","article-title":"Sodium bicarbonate for the treatment of lactic acidosis","volume":"117","author":"Forsythe","year":"2000","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ygyno.2021.01.006_bb0140","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1245\/s10434-016-5686-1","article-title":"Cytoreduction (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: retrospective Italian multicenter observational study of 511 cases","volume":"24","author":"Di Giorgio","year":"2017","journal-title":"Ann. Surg. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821000536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821000536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:57:04Z","timestamp":1758772624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821000536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0090825821000536"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.01.006","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of intra-operative factors upon peri-operative outcomes in women undergoing hyperthermic intraperitoneal chemotherapy for gynecologic cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}